Advertisement
Despite recent improvements in hypertension awareness

Younger Adults, Especially Men, Lag in HTN Treatment, Control

0
Only four in 10 with the condition get it under control, researchers say
More than half of Americans will require nursing home care at some point in their lives

Risk of Needing Nursing Home Care Is Rising

0
More short-term stays the biggest factor fueling the increase, researchers say
For patients with suspected acute myocardial infarction without hypoxemia

Oxygen Doesn’t Reduce Mortality in Suspected Acute MI

0
Routine use of supplemental oxygen does not reduce one-year all-cause mortality versus ambient air
For patients with chronic venous leg ulcers

Platelet-Rich Plasma Effective for Chronic Venous Leg Ulcers

0
Highly significant improvement in ulcer size after PRP treatment compared with conventional therapy
Clinical benefit of reduced low-density lipoprotein cholesterol levels may depend on the corresponding reduction in apolipoprotein B-containing lipoprotein particles

ApoB Levels More Closely Tied to Reduced CVD Events Than LDL

0
Change in apoB levels may be better predictor of clinical response than LDL-C, HDL-C levels
Less than 45 percent of older adults with atrial fibrillation admitted to the hospital are prescribed an anticoagulant

Less Than Half of Seniors With A-Fib Receive Anticoagulants

0
Increase in overall anticoagulant use over time, mainly due to increase in new oral anticoagulants
Most patients with immunoglobulin G subclass 4-related disease have increased levels of immunoglobulin E

Increases in IgE, Eosinophils, Mast Cells Can ID IgG4-RD

0
Levels of IgE at diagnosis may be able to identify patients with IgG4-related disease, disease relapse
Community antibacterial consumption comprises about 85 to 95 percent of total antibacterial consumption

Community Consumption Comprises Most Antibacterial Use

0
Higher proportion of community consumption in countries with high levels of total consumption
End-tidal carbon dioxide levels are prognostic for patients with chronic thromboembolic pulmonary hypertension

Tidal CO2 Prognostic for Chronic Thromboembolic Pulmonary HTN

0
ETCO2 dichotomized at 29 mm Hg significantly associated with reduced overall survival
Canakinumab at a dose of 150 mg every three months is associated with reduced rate of cardiovascular events among patients with previous myocardial infarction

Canakinumab 150 mg Tied to Reduced Rate of Cardiac Events

0
150-mg dose met prespecified threshold for significance for primary and secondary end points